Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
Virgintino
Daniela
D
La Jolla Institute for Molecular Medicine, San Diego, Calif., USA.
Ozerdem
Ugur
U
Girolamo
Francesco
F
Roncali
Luisa
L
Stallcup
William B
WB
Perris
Roberto
R
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D042501:Angiogenic Proteins / Q000378:metabolism; D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D020286:Pericytes / Q000187:drug effects* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D020533:Angiogenesis Inhibitors; D042501:Angiogenic Proteins